Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: A prospective study

Weerawat ManosuthiAroon LueangniyomkulWiroj MankatithamSukanya ChimsuntornPreecha TantanathipSupeda ThongyenBusakorn SuntisuklapponSamruay NilkamhangSomnuek SungkanuparphThailand Ministry of Public HealthMahidol University2018-05-032018-05-032011-05-01Journal of Infection. Vol.62, No.5 (2011), 406-40915322742016344532-s2.0-79956109557https://repository.li.mahidol.ac.th/handle/20.500.14594/12519Mahidol UniversityMedicineMetabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: A prospective studyLetterSCOPUS10.1016/j.jinf.2011.02.012